Trial intelligence / Profile preview

PantoCIN: Pantoprazole for Delayed CINV in Breast Cancer

NCT03948477Phase 2Completed

Sponsor
The University of Auckland
Start
Jun 2019
Primary completion
Oct 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of pantoprazole in chemotherapy-induced nausea and vomiting (CINV), sponsored by The University of Auckland. Started Jun 2019; status: completed.

02

Drugs

pantoprazole
03

Conditions

chemotherapy-induced nausea and vomiting (CINV)

Beyond the preview

Go deeper on NCT03948477.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03948477.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call